CoChat

Smad Expression in Human Atherosclerotic Lesions: Evidence for Impaired TGF-β/Smad Signaling in Smooth Muscle Cells of Fibrofatty Lesions

Kalinina, Natalia, Agrotis, Alex, Antropova, Yulia, Ilyinskaya, Olga, Smirnov, Vladimir, Tararak, Eduard, Bobik, Alex · 2004 · Arteriosclerosis, Thrombosis, and Vascular Biology
Cited by 103

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Objective— Transforming growth factor-beta (TGF-β) has been implicated in the pathogenesis of human atherosclerosis but its actions during lesion progression are poorly understood. Smad2, Smad3, and Smad4 proteins are signaling molecules by which TGF-β modulates gene transcription. Our objective was to define the actions of TGF-β during lesion progression in humans by examining the expression of Smads in relation to TGF-β–mediated responses. Methods and Results— Immunohistochemistry and reverse-transcription polymerase chain reaction demonstrated Smad2, Smad3, and Smad4 expression in macrophages of fibrofatty lesions and their upregulation after differentiation of monocytes to macrophages. The major Smad splice variants expressed by the macrophages were those that are transcriptionally most active. Macrophages also expressed cyclin inhibitors whose expression is induced via Smad proteins. The cytoplasmic location of p21 Waf1 suggests it may protect macrophages from apoptosis. Smooth muscle cells (SMCs) within the fibrofatty lesions did not express the Smad proteins or the cyclin inhibitors. SMCs of fibrous plaques expressed all 3 Smad proteins. Conclusions— In human atherosclerotic lesions, the actions of TGF-β appear restricted to SMCs in fibrous plaques and macrophages in fatty streaks/fibrofatty lesions. The lack of key TGF-β signaling components in SMCs of fibrofatty lesions indicates impaired ability of these cells to initiate TGF-β–mediated Smad-dependent transcriptional responses.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.atv.0000133605.89421.79

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 103

Metadata

Authors
Kalinina, N., Agrotis, A., Antropova, Y., Ilyinskaya, O., Smirnov, V., Tararak, E., & Bobik, A.
Venue
Arteriosclerosis, Thrombosis, and Vascular Biology
Published
2004-08
Volume
24
Issue
8
Pages
1391-1396
ISSN
  • 1079-5642 (ISSN-L)
  • 1524-4636
OpenAlex
W2162669740
Cited by
103
References
3
FWCI
1.86
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Smad Expression in Human Atherosclerotic Lesions: Evidence for Impaired TGF-β/Smad Signaling in Smooth Muscle Cells of Fibrofatty Lesions. https://app.cochat.ai/papers/10.1161/01.atv.0000133605.89421.79
The paper
Kalinina, N., Agrotis, A., Antropova, Y., Ilyinskaya, O., Smirnov, V., Tararak, E., & Bobik, A. (2004). Smad Expression in Human Atherosclerotic Lesions: Evidence for Impaired TGF-β/Smad Signaling in Smooth Muscle Cells of Fibrofatty Lesions. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/01.atv.0000133605.89421.79

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.